Is IBM Stock in Trouble?

This looks less like a one-quarter miss and more like evidence that enterprise IT budgets are rotating away from legacy software/mainframe refresh cycles toward AI infrastructure. That is structurally negative for IBM’s mix because the higher-margin, recurring pieces depend on customers prioritizing software and platform spend; if that wallet share slips, the earnings multiple should de-rate toward a lower-quality hardware/services profile. The second-order winner is the AI supply chain — especially compute and memory beneficiaries such as NVDA and MU — because constrained memory supply can keep pricing and allocation tight even if broader software demand softens.

Near term, the biggest risk is that analysts cut forward numbers faster than the stock has adjusted. For a name trading on “defensive compounder” assumptions, a small revenue miss can trigger a larger multiple reset if investors start modeling slower subscription growth and weaker mainframe attach rates over the next 1-2 quarters. The first catalyst window is this week’s full print and guide; the next is whether management confirms the weakness is demand-driven rather than just a temporary component shortage.

The contrarian case is that the selloff may already be discounting a fairly severe slowdown, while the actual issue could be supply timing plus budget deferral rather than outright share loss. Still, this is not an obvious deep-value setup until the market sees evidence that software renewal momentum and free cash flow conversion are intact. If IBM can’t stabilize guidance or if the next quarter shows continued mix shift into lower-margin infrastructure, the downside path extends over 6-18 months rather than being a one-day overreaction.